세계의 CBD 뉴트라슈티컬 시장 : 산업 분석, 시장 규모, 점유율, 성장, 동향 및 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the global CBD Nutraceuticals Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• CBD Nutraceuticals Market Size (2025E): US$ 10.4 Bn
• Projected Market Value (2032F): US$ 23.4 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 12.3%

CBD Nutraceuticals Market - Report Scope:

The CBD nutraceuticals market includes a broad array of dietary and wellness products derived from cannabidiol (CBD), such as gummies, tinctures, capsules, and topicals. These products are widely consumed for their therapeutic benefits, particularly in pain relief, sleep support, skin health, and wellness. With the growing global acceptance of cannabis-based products and a shift towards natural health supplements, the market is witnessing rapid expansion. Increased legalization and changing consumer preferences toward plant-based wellness solutions continue to fuel this growth.

Market Growth Drivers:

Several key factors are fueling the growth of the global CBD nutraceuticals market. Increasing awareness about the therapeutic benefits of CBD, including its anti-inflammatory, analgesic, and anxiolytic properties, is significantly boosting consumer demand. Rising health and wellness consciousness, especially among millennials and Gen Z, has created a fertile ground for CBD-based functional products. In addition, the gradual legalization of cannabis and CBD in several countries has eased regulatory barriers, enabling product innovation and wider distribution. The expansion of e-commerce platforms has also enhanced product accessibility, driving market penetration.

Market Restraints:

Despite its strong growth trajectory, the CBD nutraceuticals market faces notable challenges. Regulatory inconsistencies across different countries and regions hinder the seamless trade and marketing of CBD products. Moreover, the lack of standardized dosing and limited clinical validation for some health claims raises concerns among consumers and medical professionals. Misinformation and stigma surrounding cannabis-related products also contribute to consumer hesitancy. Additionally, high product costs and limited insurance coverage for alternative wellness products may restrict adoption, particularly in price-sensitive markets.

Market Opportunities:

The market presents substantial growth opportunities fueled by ongoing research into the medical benefits of CBD and increasing demand for personalized nutrition. Innovations in product formulations-such as nanoemulsions for better bioavailability-are creating new revenue streams. The rise in consumer preference for vegan, organic, and clean-label products provides a strong platform for CBD-infused nutraceuticals. Emerging markets in Asia-Pacific and Latin America, where awareness is growing and regulations are gradually evolving, also offer untapped potential. Collaborations between CBD brands and mainstream food, pharma, and wellness companies could further expand market reach and trust.

Key Questions Answered in the Report:

• What are the primary factors driving the global CBD nutraceuticals market's growth?
• Which regions and product segments are witnessing the highest demand for CBD nutraceuticals?
• How are advancements in formulation and delivery methods influencing market dynamics?
• Who are the key players in the CBD nutraceuticals market, and what are their strategic approaches?
• What are the latest trends and future projections for the global CBD nutraceuticals market?

Competitive Intelligence and Business Strategy:

Leading companies in the global CBD nutraceuticals market such as GVB Biopharma, Charlotte's Web, Inc., Elixinol, and CV Sciences, Inc. are heavily investing in product innovation, clinical validation, and brand-building efforts. These players are focusing on broadening their product portfolios with targeted solutions for pain relief, sleep, and beauty. Strategic partnerships with retailers, pharmacies, and digital platforms are helping companies expand distribution. Additionally, emphasis on transparency, third-party lab testing, and sustainable sourcing is building consumer trust and fostering long-term brand loyalty.

Companies Covered in This Report:

• GVB Biopharma
• Brains
• NOW
• Dr. CBD Company Limited
• dsm-firmenich
• Charlotte's Web, Inc.
• Elixinol
• Medical Marijuana, Inc.
• CV Sciences, Inc.
• Irwin Naturals
• Diamond CBD
• Foria Wellness (Eden Partners LLC)
• Medterra CBD

Market Segmentation:

By Product:

• CBD Gummies
• CBD Tinctures
• Capsules and Softgels
• Salves and Balms
• Others

By Form:

• Ingestibles
• Topicals

By Application:

• Pain Management
• Sleep Support
• Skin Health and Beauty
• Workout Supplements
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Middle East and Africa
• Latin America

Table of Contents

1. Executive Summary

• 1.1. Global CBD Nutraceuticals Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. PESTLE Analysis
• 3.5. Porter's Five Force Analysis

4. Global CBD Nutraceuticals Market Outlook

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 4.3. Global CBD Nutraceuticals Market Outlook: Product
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
    • 4.3.3.1. CBD Gummies
    • 4.3.3.2. CBD Tinctures
    • 4.3.3.3. Capsules & Softgels
    • 4.3.3.4. Salves & Balms
    • 4.3.3.5. Others
  • 4.3.4. Market Attractiveness Analysis: Product
• 4.4. Global CBD Nutraceuticals Market Outlook: Form
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Bn), By Form, 2019-2024
  • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
    • 4.4.3.1. Ingestible
    • 4.4.3.2. Topical
  • 4.4.4. Market Attractiveness Analysis: Form
• 4.5. Global CBD Nutraceuticals Market Outlook: Application
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn), By Application, 2019-2024
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 4.5.3.1. Pain Management
    • 4.5.3.2. Sleep Support
    • 4.5.3.3. Skin Health & Beauty
    • 4.5.3.4. Workout Supplements
    • 4.5.3.5. Others
  • 4.5.4. Market Attractiveness Analysis: Application
• 4.6. Global CBD Nutraceuticals Market Outlook: Distribution Channel
  • 4.6.1. Introduction / Key Findings
  • 4.6.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
  • 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 4.6.3.1. Hospital Pharmacies
    • 4.6.3.2. Retail Pharmacies
    • 4.6.3.3. Online Pharmacies
  • 4.6.4. Market Attractiveness Analysis: Distribution Channel

5. Global CBD Nutraceuticals Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America CBD Nutraceuticals Market Outlook

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Product
  • 6.2.3. By Form
  • 6.2.4. By Application
  • 6.2.5. By Distribution Channel
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
  • 6.4.1. CBD Gummies
  • 6.4.2. CBD Tinctures
  • 6.4.3. Capsules & Softgels
  • 6.4.4. Salves & Balms
  • 6.4.5. Others
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
  • 6.5.1. Ingestible
  • 6.5.2. Topical
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 6.6.1. Pain Management
  • 6.6.2. Sleep Support
  • 6.6.3. Skin Health & Beauty
  • 6.6.4. Workout Supplements
  • 6.6.5. Others
• 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 6.7.1. Hospital Pharmacies
  • 6.7.2. Retail Pharmacies
  • 6.7.3. Online Pharmacies
• 6.8. Market Attractiveness Analysis

7. Europe CBD Nutraceuticals Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Form
  • 7.2.4. By Application
  • 7.2.5. By Distribution Channel
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
  • 7.4.1. CBD Gummies
  • 7.4.2. CBD Tinctures
  • 7.4.3. Capsules & Softgels
  • 7.4.4. Salves & Balms
  • 7.4.5. Others
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
  • 7.5.1. Ingestible
  • 7.5.2. Topical
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 7.6.1. Pain Management
  • 7.6.2. Sleep Support
  • 7.6.3. Skin Health & Beauty
  • 7.6.4. Workout Supplements
  • 7.6.5. Others
• 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 7.7.1. Hospital Pharmacies
  • 7.7.2. Retail Pharmacies
  • 7.7.3. Online Pharmacies
• 7.8. Market Attractiveness Analysis

8. East Asia CBD Nutraceuticals Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Form
  • 8.2.4. By Application
  • 8.2.5. By Distribution Channel
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
  • 8.4.1. CBD Gummies
  • 8.4.2. CBD Tinctures
  • 8.4.3. Capsules & Softgels
  • 8.4.4. Salves & Balms
  • 8.4.5. Others
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
  • 8.5.1. Ingestible
  • 8.5.2. Topical
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 8.6.1. Pain Management
  • 8.6.2. Sleep Support
  • 8.6.3. Skin Health & Beauty
  • 8.6.4. Workout Supplements
  • 8.6.5. Others
• 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 8.7.1. Hospital Pharmacies
  • 8.7.2. Retail Pharmacies
  • 8.7.3. Online Pharmacies
• 8.8. Market Attractiveness Analysis

9. South Asia & Oceania CBD Nutraceuticals Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Form
  • 9.2.4. By Application
  • 9.2.5. By Distribution Channel
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
  • 9.4.1. CBD Gummies
  • 9.4.2. CBD Tinctures
  • 9.4.3. Capsules & Softgels
  • 9.4.4. Salves & Balms
  • 9.4.5. Others
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
  • 9.5.1. Ingestible
  • 9.5.2. Topical
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 9.6.1. Pain Management
  • 9.6.2. Sleep Support
  • 9.6.3. Skin Health & Beauty
  • 9.6.4. Workout Supplements
  • 9.6.5. Others
• 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 9.7.1. Hospital Pharmacies
  • 9.7.2. Retail Pharmacies
  • 9.7.3. Online Pharmacies
• 9.8. Market Attractiveness Analysis

10. Latin America CBD Nutraceuticals Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Form
  • 10.2.4. By Application
  • 10.2.5. By Distribution Channel
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
  • 10.4.1. CBD Gummies
  • 10.4.2. CBD Tinctures
  • 10.4.3. Capsules & Softgels
  • 10.4.4. Salves & Balms
  • 10.4.5. Others
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
  • 10.5.1. Ingestible
  • 10.5.2. Topical
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 10.6.1. Pain Management
  • 10.6.2. Sleep Support
  • 10.6.3. Skin Health & Beauty
  • 10.6.4. Workout Supplements
  • 10.6.5. Others
• 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 10.7.1. Hospital Pharmacies
  • 10.7.2. Retail Pharmacies
  • 10.7.3. Online Pharmacies
• 10.8. Market Attractiveness Analysis

11. Middle East & Africa CBD Nutraceuticals Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Form
  • 11.2.4. By Application
  • 11.2.5. By Distribution Channel
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
  • 11.4.1. CBD Gummies
  • 11.4.2. CBD Tinctures
  • 11.4.3. Capsules & Softgels
  • 11.4.4. Salves & Balms
  • 11.4.5. Others
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
  • 11.5.1. Ingestible
  • 11.5.2. Topical
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 11.6.1. Pain Management
  • 11.6.2. Sleep Support
  • 11.6.3. Skin Health & Beauty
  • 11.6.4. Workout Supplements
  • 11.6.5. Others
• 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
  • 11.7.1. Hospital Pharmacies
  • 11.7.2. Retail Pharmacies
  • 11.7.3. Online Pharmacies
• 11.8. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. GVB Biopharma
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Brains
  • 12.3.3. NOW
  • 12.3.4. Dr. CBD Company Limited
  • 12.3.5. dsm-firmenich
  • 12.3.6. Charlotte's Web, Inc.
  • 12.3.7. Elixinol
  • 12.3.8. Medical Marijuana, Inc.
  • 12.3.9. CV Sciences, Inc.
  • 12.3.10. Irwin Naturals
  • 12.3.11. Diamond CBD
  • 12.3.12. Foria Wellness (Eden Partners LLC)
  • 12.3.13. Medterra CBD
  • 12.3.14. Green Roads
  • 12.3.15. Isodiol International Inc
  • 12.3.16. Garden of Life
  • 12.3.17. Bluebird Botanicals (Gaia Botanicals, LLC)
  • 12.3.18. Endoca
  • 12.3.19. One Farm
  • 12.3.20. Treadwell Farms
  • 12.3.21. CBD Worx
  • 12.3.22. USA Medical
  • 12.3.23. NuLeaf Naturals, LLC
  • 12.3.24. EarlyBird CBD

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations